Live Terminal | Security Analysis of BIO3.DE
TERMINAL beta
Version: 0.1
Timestamp: 1709197736.726208
Options
0Q3.F
53.76%
006220.KS
49.51%
B7J.DE
48.43%
000540.KS
48.07%
BBAI-WT
47.26%
HANA.L
-44.06%
PHLL.L
-50.14%
RAL.PA
-52.20%
GOLL4.SA
-52.40%
HGEN.L
-54.91%
AAPL $180.88 -0.96%
AMD $176.37 -0.92%
AMZN $173.96 0.24%
BRK-B $413.02 1.01%
GOOG $137.26 -2.03%
IBM $184.92 0.03%
INTC $42.16 -1.35%
JNJ $161.21 0.14%
JPM $184.74 0.70%
META $487.18 0.03%
MSFT $407.70 0.05%
O $52.16 -0.28%
TSLA $203.55 1.91%
WMT $59.72 0.21%
QQQ $435.27 -0.5325%
TLT $93.52 0.6349%
VUAA.DE $87.92 -0.3875%
VUSA.DE $88.54 -0.4475%
FJPR.L $5.63 -0.5650%
VWRL.L $98.13 -0.0713%
VWRP.L $97.38 -0.1333%
EMGU.L $3.56 0.4372%
RDVY $52.62 -0.1518%
FLOT $51.04 0.0294%
SCHZ $45.68 0.2414%
IBB $139.42 -1.0434%
C020.DE $21.34 0.0000%
DFAX $24.53 -0.6480%
LYP6.DE $225.40 0.2000%
MEUD.PA $225.53 0.2311%
IQQW.DE $65.30 -0.1712%
IDWR.L $70.89 -0.0775%
EXS1.DE $147.56 0.2446%
XESC.L $6914.43 0.2092%
DFAU $35.18 -0.2269%
ACWV $103.29 -0.3377%
VHYD.L $63.71 0.0393%
VGWD.DE $58.75 -0.0340%
FXKZ.ME $303.00 0.0000%

Latest articles

No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.

Sentiment statistics ?
BIO3.DE
μ null
null
null

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
BIO3.DE
Latest Performance
BIO3.DE$28.40
$0.40 • 1.43%
BIO3.DE
Price 28.40
Change Pct 1.43
Change Abs 0.40
Market Cap 1.4 billion
Eps 2.29
Pe Ratio 12.40
Outstanding Shares 49.6 million
Volume 2405
Avg Volume 574
Industry Biotechnology
Sector Name Health Care
Country Short Name DE
Announcement Earnings 2023-03-31 04:00:00+00:00
All metrics in USD or %.
Dividends

There is no dividend data to display. Refer our Dividend calendar for other accurate data.

Risk Profiles

Please sign up and become a member to view all risk profiles.

Competitors/Peer Groups
BIO3.DE
Same Country:
Same Decade:
Intraday: -0.71%
Focus

The 'Focus' Area is meant to be an One-Pager about all Important Insights, Risks and Opportunities to solely analyze a single corporate.

Company descriptions
BIO3.DE

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis;